Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters
Authors:
Preprint
Abstract
The SARS-CoV-2 Omicron (B.1.1.529) variant has proven highly transmissible and has outcompeted the Delta variant in many regions of the world 1 . Early reports have also suggested that Omicron may result in less severe clinical disease in humans. Here we show that Omicron is less pathogenic than prior SARS-CoV-2 variants in Syrian golden hamsters. Infection of hamsters with the SARS-CoV-2 WA1/2020, Alpha, Beta, or Delta strains led to 4-10% weight loss by day 4 and 10-17% weight loss by day 6, as expected 2,3 . In contrast, infection of hamsters with two different Omicron challenge stocks did not result in any detectable weight loss, even at high challenge doses. Omicron infection still led to substantial viral replication in both the upper and lower respiratory tracts and pulmonary pathology, but with a trend towards higher viral loads in nasal turbinates and lower viral loads in lung parenchyma compared with WA1/2020 infection. These data suggest that the SARS-CoV-2 Omicron variant may result in more robust upper respiratory tract infection but less severe lower respiratory tract clinical disease compared with prior SARS-CoV-2 variants.Keywords
All Related Versions
- Published version: Med, 3 (4), 262.
This publication has 10 references indexed in Scilit:
- SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infectionmedRxiv, 2021
- Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concernScience Translational Medicine, 2021
- Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus MacaquesJournal of Virology, 2021
- Animal models for COVID-19Nature, 2020
- Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamstersNature Medicine, 2020
- DNA vaccine protection against SARS-CoV-2 in rhesus macaquesScience, 2020
- Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure developmentProceedings of the National Academy of Sciences, 2020
- Pathogenesis and transmission of SARS-CoV-2 in golden hamstersNature, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and TransmissibilityClinical Infectious Diseases, 2020